When your patient asks if there's a higher-capacity option, remind them that bigger hardware doesn't necessarily mean better pharmacokinetics. The real question is whether they're treating symptoms or just collecting peripherals. Via...
Cannabis Meets Drug Metabolism: What We Know—and Don’t Know—About Cannabinoids and CYP450 Enzymes
Recognising potential interactions between cannabinoids and other drugs could enhance understanding of their pharmacological effects, improve the efficacy and safety profiles of cannabinoid-based therapies, and encourage further exploration into this under-researched area of psychopharmacology.
Nowadays Spicy Lime 10 Mg Thc Thc Cocktail, Spicy Lime – EWG’s Food Scores
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic EdiblesDosingPharmacokineticsPatient EducationProduct Safety Why This MattersCannabis-infused beverages represent a rapidly growing product category with...
Federally Funded Study Reveals Marijuana Breathalyzer Breakthrough With 3-D Printed …
✦ New CED Clinical Relevance #92High Clinical Relevance Strong evidence or policy relevance with direct clinical implications. ⚒ Cannabis News | CED Clinic Impairment DetectionPharmacokineticsSafetyThcClinical Tools Why This MattersCurrent roadside impairment detection relies on subjective field...
Ever think about how we actually measure THC impairment in the real world? Because … – Facebook
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic Impairment TestingThc PharmacokineticsPatient SafetyLegal MedicineDosing Why This MattersCurrent THC impairment testing relies on blood...
Faster cannabinoid bioavailability, a study
This cannabinoid bioavailability review looks at a 2025 crossover study testing a nanoemulsified THC/CBD powder against standard oil drops in healthy volunteers. The study found faster absorption and higher cannabinoid exposure with the powder formulation. But cannabinoid bioavailability is not the same as proven clinical benefit, and that distinction matters for patients, providers, and policymakers.
Florida bar offers hemp, THC crafted cocktails, hip decor, new events
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic EdiblesSocial UseDosingBeveragesPharmacokinetics Why This MattersThe emergence of THC-infused beverages in licensed establishments represents a...
DC mayor proposes allowing cannabis drinks – NBC4 Washington
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic EdiblesPolicyDosingPatient SafetyPharmacokinetics Why This MattersCannabis beverages represent a distinct delivery method with different onset...
PharmDs Explain What Happens When You Mix CBD and Alcohol Together
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic Drug InteractionsCbdHepatic MetabolismPatient SafetyPharmacokinetics Why This MattersPatients frequently combine CBD with alcohol without understanding...
Cannabis Pharmacokinetics Review: THC, CBD, Dosing
This paper is a broad evidence review of human pharmacokinetic studies on THC and CBD. It helps clarify how route, formulation, food, sex, drug interactions, and patient factors can meaningfully change absorption and exposure. Its main limitation is that it synthesizes heterogeneous studies rather than providing one unified, practice-ready dosing framework.